Clinical Trial Update: Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo [Phase 4]

View source ↗

Summary

This document updates a Phase 4 clinical trial comparing topical tacrolimus 0.1% to topical mometasone furoate 0.1% for adult vitiligo. The study assesses compa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Mometasone furoate 0.1% topical (mometasone furoate)
• Tacrolimus 0.1% topical (tacrolimus)

Snippet

Sponsor: Mahidol University | Conditions: Vitiligo | Phase 4 | Status: UNKNOWN